Detalhe da pesquisa
1.
Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infection.
Eur J Immunol
; 54(1): e2350633, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37799110
2.
Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers.
Int J Mol Sci
; 24(8)2023 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37108566
3.
Toxic and nutritional factors trigger Leber hereditary optic neuropathy due to a mitochondrial tRNA mutation.
Clin Genet
; 102(4): 339-344, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35808913
4.
Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment.
Mediators Inflamm
; 2019: 8147803, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31346315
5.
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.
Mult Scler
; 24(14): 1843-1851, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28984163
6.
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.
J Clin Med
; 12(23)2023 Nov 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38068295
7.
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Neurol Ther
; 12(6): 2177-2193, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37861931
8.
Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.
J Clin Med
; 11(9)2022 Apr 29.
Artigo
Inglês
| MEDLINE | ID: mdl-35566632
9.
Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-ß in a Preclinical Model of Multiple Sclerosis.
Biomedicines
; 9(12)2021 Nov 24.
Artigo
Inglês
| MEDLINE | ID: mdl-34944573
10.
Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab.
J Pers Med
; 11(12)2021 Dec 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34945819
11.
MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients.
Front Immunol
; 10: 1251, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31293564
12.
Optimal response to dimethyl fumarate is mediated by a reduction of Th1-like Th17 cells after 3 months of treatment.
CNS Neurosci Ther
; 25(9): 995-1005, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31066225
13.
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.
Clin Chim Acta
; 488: 135-142, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30408481
14.
Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration.
BMJ Open
; 9(9): e030309, 2019 09 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31501122
15.
Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients.
Cytometry B Clin Cytom
; 94(2): 327-333, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28378895
16.
Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients.
CNS Neurosci Ther
; 24(12): 1175-1184, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29656444
17.
Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.
Neurodegener Dis Manag
; 5(5): 399-402, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26517599
18.
Efficacy of mefloquine and mirtazapine on progressive multifocal leukoencephalopathy in a patient with peripheral T-cell lymphoma. / Eficacia de mefloquina y mirtazapina sobre la leucoencefalopatía multifocal progresiva en un paciente con linfoma T periférico.
Med Clin (Barc)
; 153(9): e47-e48, 2019 11 15.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-30803799
19.
Spinal melanocytoma with leptomeningeal spread and long survival following surgery and chemotherapy.
J Neurosurg Sci
; 62(3): 375-378, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27676283
20.
Eficacia de mefloquina y mirtazapina sobre la leucoencefalopatía multifocal progresiva en un paciente con linfoma T periférico / Efficacy of mefloquine and mirtazapine on progressive multifocal leukoencephalopathy in a patient with peripheral T-cell lymphoma
Med. clín (Ed. impr.)
; 153(9): e47-e48, nov. 2019. ilus
Artigo
Espanhol
| IBECS (Espanha) | ID: ibc-186273